RapidAI Announces Amit Phadnis as New Chief Innovation and Technology Officer

“We are thrilled to have Amit join us at RapidAI as we continue to advance our platform and suite of products to provide better care for patients around the world,” said Karim Karti, CEO of RapidAI. “His vast experience in technology, artificial intelligence, and clinical imaging will serve the team well as we deliver the future of clinical technology for life-threatening diseases.”

Amit joins RapidAI with 30 years of experience in leading global product teams. In his role at GE, Amit was responsible for driving the company’s digital and AI strategy, as well as GE Healthcare’s complete digital portfolio, including enterprise imaging solutions, Clinical Command Centers and consulting solutions. With his global digital team, Amit enabled GE’s vision for precision health by creating the industry-leading Edison platform and its cloud, edge, device software infrastructure, data strategy, SaaS enablement, artificial intelligence, and analytics capabilities.

Prior to GE, Amit was with Cisco Systems, where he was the India Site Leader and Senior Vice President of Engineering for the Core Software Group, leading product development activities across the routing, switching and wireless areas. Amit has also previously held leadership roles at Motorola, Tata Elxsi, Silicon Automation Systems, and C-DOT. He earned his master’s degree in electronics and communication from the Indian Institute of Science.

“I look forward to working with the talented technologists, engineers, and sales leaders at RapidAI, to advance our artificial intelligence platform and meaningfully improve physician workflow and patient outcomes,” said Phadnis. “I was drawn to RapidAI because of its unique suite of products and incredible leadership in the industry. I am grateful for the opportunity to bring my experience to the team and continue to develop technology that pushes the boundaries of care.”

​​As the Chief Innovation and Technology Officer at RapidAI, Amit will oversee the R&D, Engineering and Technology organizations, driving the advancement of the RapidAI comprehensive AI and Workflow Platform for neurovascular and vascular disease care and beyond.

RapidAI’s platform leverages AI to create enhanced, high-quality images from NCCT, CTA, CTP and MRI diffusion and perfusion data, which are available to physicians on web and mobile devices. The technology helps physicians make expedient diagnoses and treatment and transfer decisions, and allows for more streamlined communication and coordination of the patient journey. Though its foundations are in the treatment of stroke, RapidAI’s technology has been evolved to apply to several other disease states, with continued advancements to come in the future. In August, RapidAI reached more than 4 million scans on its platform – the most clinically advanced in the industry.

About RapidAI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money. For more information, visit www.RapidAI.com.